Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the benefit of adding docetaxel-5 fluorouracile (D-5FU) regimen after
pre-operative epirubicin-cyclophosphamide (EC) and loco-regional treatment in inflammatory
breast cancer (IBC).